Stimunity
65 posts
Stimunity
@StimunityBio
Biopharmaceuticals to treat patients that do not respond to conventional immunotherapy.
Paris, France Katılım Nisan 2016
329 Takip Edilen186 Takipçiler
Nothing would do more to improve the health, lifespan and quality of life for Americans than making GLP inhibitors super low cost to the public.
Nothing else is even close.
Jeremy Kauffman 🦔🌲🌕@jeremykauffman
Luigi Mangione's manifesto includes a superficially damning claim. However, it's wrong. Want to understand why the US spends so much on healthcare to get such poor results? Read this thread to see the greatest (and most unknown) analysis of US healthcare ever done.
English
Stimunity retweetledi
Watch how a T cell kills a cancer cell. Our immune system is incredible!
English
Stimunity retweetledi
Caspases and their IL-1 family substrates are among the earliest discovered agents of innate immunity. Yet with no structural insight, we still do not understand how caspases cleave cytokines. What other mysteries of innate immunity remain?
English
Stimunity retweetledi
𝟐𝟎𝟎𝟑 - 𝟐𝟎𝟐𝟑 : 𝟐𝟎 𝒂𝒏𝒔 𝒂𝒖𝒙 𝒄𝒐̂𝒕𝒆́𝒔 𝒅𝒆 𝒍’𝑨𝒔𝒔𝒐𝒄𝒊𝒂𝒕𝒊𝒐𝒏 𝑬𝒓𝒊𝒄 𝑻𝒂𝒃𝒂𝒓𝒍𝒚 💙
Remportez une navigation pour 2 personnes sur l’un des mythiques Pen Duick !
Pour jouer :
- Suivez notre page
- Retweetez ce post
Tirage 9/10 à 11h.
#PassionVoile
Français
Stimunity retweetledi
#ASCO23 | Therapeutic vaccine in anogenital #cancer and epigenetic drug 🧬
2 innovative approaches evaluated in studies presented at #ASCO23 by Prof. Christophe Le Tourneau @Institut_Curie, with promising results.
Abstracts:
➡️meetings.asco.org/abstracts-pres…
➡️meetings.asco.org/abstracts-pres…
English
Stimunity retweetledi
📸 En marge de l'annonce des nouveaux programmes d'excellence Innovation Santé 2030 à l'Institut Curie, @EmmanuelMacron et Brigitte Macron se sont rendus dans les services de l'institut à St Cloud pour échanger avec nos experts et rencontrer nos équipes.
#France2030
Français
Stimunity retweetledi
Ravie de célébrer avec nos partenaires, le lancement opérationnel du Paris Saclay Cancer Cluster, en présence de @FrcsBraun, @sretailleau, @RolandLescure & @vpecresse.
Soyons fier de notre ambition en oncologie pour les patients & la 🇫🇷! #SanofiFR
Français
Stimunity retweetledi
Not all STING agonists are the same. A powerful new strategy using STING agonists in VLPs stimulates protective immunity. Kudos to Manel and colleagues on this fantastic study.
@NicolasManelLab
science.org/doi/10.1126/sc…
English
@AlanWoo13116320 @OrcaStocks That’s why most people work on therapeutic vaccine (not prophylactic)
English
@OrcaStocks @StimunityBio #AVCT How many years will it take before we would know cancer vaccines are a success. I mean take the vaccine at the age of 20...you might not be destined to develop cancer until your 70.
English
@OrcaStocks Our 1st program is an immuno-modulator which is a kind of therapeutic vaccine that uses the antigen in your body.
English
@OrcaStocks mRNA vaccine will struggle with the most difficult part which is to identify tumor antigen individually.
English
Stimunity retweetledi
Après un premier événement la semaine passée au Collège de France, la seconde cérémonie annuelle de remise des Prix 2022 de la FRM s'est tenue hier soir à la Maison de la Recherche. Bravo aux lauréats !
Plus d'infos sur les Prix et leurs lauréats 2022 : frm.org/nos-publicatio…
Français
Stimunity retweetledi
Stimunity retweetledi
Visit us at the AACR 2022 late-breaking poster session. @BakhosJ will be there to present our preclinical work on our lead candidate STI-001 on STING !
stimunity.com/static/Stimuni…
English
Stimunity retweetledi
🦠Les virus émergents, par leur caractère soudain et leur facilité de propagation, constituent un véritable enjeu mondial de santé publique.
Pour en savoir plus : frm.org/virus-emergents
Français
@samagyabanskota This is so exciting! But when in time do you think it can be a clinically benefit? In 5 years? 10? 15?
English
Excited to share our work describing engineered virus-like particles (eVLPs) for in vivo delivery of therapeutic proteins, that is out today in Cell! Very thankful for the talented team that made this possible, in particular my co-first author Aditya Raguram.
David R. Liu@davidrliu
Today we report in @CellCellPress an engineered virus-like particle (eVLP) platform that mediates efficient in vivo delivery of therapeutic proteins, including base editors and Cas9 nuclease, resulting in therapeutic editing in multiple mouse organs. 1/14 drive.google.com/file/d/1GdJLA4…
English
Stimunity retweetledi
No Longer A One-Trick Pony: STING Signaling Activity Beyond Interferon sciencedirect.com/science/articl…
English